CN109628424A - 一种新型嵌合dna聚合酶及其制备方法 - Google Patents

一种新型嵌合dna聚合酶及其制备方法 Download PDF

Info

Publication number
CN109628424A
CN109628424A CN201811651584.3A CN201811651584A CN109628424A CN 109628424 A CN109628424 A CN 109628424A CN 201811651584 A CN201811651584 A CN 201811651584A CN 109628424 A CN109628424 A CN 109628424A
Authority
CN
China
Prior art keywords
domain
polymerase
dna polymerase
archaeal dna
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811651584.3A
Other languages
English (en)
Other versions
CN109628424B (zh
Inventor
吴亚会
位小丫
李新瑞
任加庆
臧赢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WUJIANG NOVOPROTEIN TECHNOLOGY Co Ltd
Original Assignee
WUJIANG NOVOPROTEIN TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WUJIANG NOVOPROTEIN TECHNOLOGY Co Ltd filed Critical WUJIANG NOVOPROTEIN TECHNOLOGY Co Ltd
Priority to CN201811651584.3A priority Critical patent/CN109628424B/zh
Publication of CN109628424A publication Critical patent/CN109628424A/zh
Application granted granted Critical
Publication of CN109628424B publication Critical patent/CN109628424B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1252DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07007DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

本发明开发了一种新型的嵌合DNA聚合酶,在一些实施方式中,根据本发明设计的嵌合聚合酶具有基本上类似于第一DNA聚合酶的持续合成能力、延伸率和热稳定性以及基本上类似于第二DNA聚合酶的保真性。本发明的第一DNA聚合酶是KOD聚合酶SEQ ID No.1,第二DNA聚合酶是Pfu聚合酶SEQ ID No.2。本发明技术方案利用高保真DNA聚合酶中功能区切换,结合不同DNA聚合酶的期望的功能特性。本发明尤其提供了稳健、快速以及准确的DNA聚合酶,用于DNA扩增、合成、检测、测序以及其它重要的重组DNA技术。发明的创新的高保真DNA聚合酶是一种同时具有高保真性,高持续合成能力,高延伸率,热稳定性,对盐有耐受性的高保真DNA聚合酶。

Description

一种新型嵌合DNA聚合酶及其制备方法
技术领域
本发明属于分子和细胞生物学领域,特别涉及DNA聚合酶。
背景技术
DNA聚合酶,又称DNA依赖的DNA聚合酶(DNA—dependent DNApolymerase,DNApol),它以DNA单链为模版,以4种脱氧核苷酸为底物由5'端点开始复制合成一条与模版链序列互补的DNA新链。高保真DNA聚合酶具有3'到5'核酸外切酶的活性,PCR扩增途中如果产生了错配的碱基,它可以将其切掉,从而保证了扩增的准确性。普通DNA聚合酶(如taqDNA聚合酶)的错配率在10-5,而高保真DNA聚合酶错配率可降到10-6甚至10-7,大大降低了出错的可能性;它适合对PCR保真性要求较高的实验,如基因筛选、测序、突变检测等。
然而,高保真DNA聚合酶的优点被它的相对低的持续合成能力(其会降低DNA扩增产物的产率)所抵消。Pfu DNA聚合酶(Pfu DNA polymerase),又称Pfu聚合酶,是在嗜热的古核生物火球菌属内发现的,在所有热稳定性聚合酶中Pfu DNA聚合酶的错误几率最低,错误率约为2.0x10-6,然而Pfu酶扩增伸速度缓慢(25nts/s),扩增产量较低(~20nts),给众多的使用者带来了不便。KOD DNA聚合酶是从日本鹿儿岛县小宝(Kodakara)岛的含硫气孔中分离出来的超嗜热原始菌Thermococcus kodakaraensis KOD1分离出来的具有高扩增能力的DNA聚合酶,其扩增速度是Taq酶的2倍,Pfu酶的6倍,扩增产量较高(~300nts)(takagiet al.1997)。
发明内容
本发明技术方案利用高保真DNA聚合酶中功能区切换,结合不同DNA聚合酶的期望的功能特性(例如,高持续合成能力,高延伸率,热稳定性,对盐、PCR添加物的抗性,以及高保真性)。因此,本发明尤其提供了稳健、快速以及准确的DNA聚合酶,用于DNA扩增、合成、检测、测序以及其它重要的重组DNA技术。
根据本发明其中一种技术方案开发了一种新型的嵌合DNA聚合酶,本发明的方法包括以下步骤:(a)提供基于第一DNA聚合酶的N-末端域、核酸外切酶域、掌和指域以及拇指域;(b)提供基于第二DNA聚合酶的核酸外切酶域;(c)结合来自步骤(a)和步骤(b)的域以形成嵌合聚合酶;其中嵌合聚合酶具有高于第一DNA聚合酶的保真性以及高于第二DNA聚合酶的持续合成能力、延伸率和热稳定性。在一些实施方式中,根据本发明设计的嵌合聚合酶具有基本上类似于第一DNA聚合酶的持续合成能力、延伸率和热稳定性以及基本上类似于第二DNA聚合酶的保真性。本发明的第一DNA聚合酶是KOD聚合酶SEQ ID No.1,第二DNA聚合酶是Pfu聚合酶SEQ ID No.2。
根据本发明其中一种技术方案提供了一种新型的嵌合DNA聚合酶,该嵌合DNA聚合酶包含第一域和第二域,
第一域取自第一DNA聚合酶中的氨基酸序列,第一DNA聚合酶的特征在于延伸率、高持续合成能力、热稳定性;
第二域取自第二DNA聚合酶中的氨基酸序列,第二DNA聚合酶的特征在于高保真性;嵌合DNA聚合酶的特征在于高保真性和高持续合成能力、延伸率、热稳定性。
根据本发明其中一种技术方案提供了嵌合聚合酶,上述第一DNA聚合酶选自KOD聚合酶
根据本发明其中一种技术方案提供了嵌合聚合酶,上述第二DNA聚合酶选自Pfu聚合酶。
根据本发明其中一种技术方案提供了嵌合聚合酶,上述一个DNA聚合酶是KOD聚合酶,而所述另一个DNA聚合酶是Pfu聚合酶。
根据本发明其中一种技术方案提供了嵌合聚合酶,该酶为上述任意一种嵌合聚合酶,其中第一域选自N-末端域、拇指域以及掌域和指域。
根据本发明其中一种技术方案提供了嵌合聚合酶,该酶为上述任意一种嵌合聚合酶,其中第二域是核酸外切酶域。
根据本发明其中一种技术方案提供了嵌合聚合酶,该酶为上述任意一种嵌合聚合酶,其中第一DNA聚合酶中所述氨基酸序列对应于KOD聚合酶(如SEQ ID No.4所示)的氨基酸残基N-末端域,掌域,指域和拇指域。
根据本发明其中一种技术方案提供了嵌合聚合酶,其中第二DNA聚合酶中所述氨基酸序列对应于Pfu聚合酶(如SEQ ID No.5所示)的氨基酸残基核酸外切酶域。
根据本发明其中一种技术方案提供了嵌合聚合酶,其中嵌合聚合酶的氨基酸序列相同于SEQ ID No.6,其中,嵌合聚合酶具有高于KOD的保真性以及高于Pfu的持续合成能力、延伸率和热稳定性。
本发明技术方案还提供了一种嵌合聚合酶,该嵌合聚合酶包括第一域和第二域,
第一域,取第一DNA聚合酶中的氨基酸序列N-末端域、拇指域以及掌域和指域;
第二域,取自第二DNA聚合酶中的氨基酸序列核酸外切酶域,其中,所述嵌合聚合酶具有高于所述第二DNA聚合酶的持续合成能力、延伸率、热稳定性,以及高于所述第一DNA聚合酶的保真性。
本发明技术方案还提供了一种嵌合聚合酶,该嵌合聚合酶包括至少80%相同于SEQ ID No.6的氨基酸序列。
本发明技术方案还提供了一种核苷酸序列,该核苷酸序列编码根据上述技术方案中任意一种的嵌合聚合酶氨基酸序列而编码。
本发明技术方案还提供了一种DNA合成的方法,该DNA合成的方法使用上述任意一种嵌合聚合酶进行DNA合成的方法。
本发明技术方案还提供了一种设计嵌合聚合酶的方法,该方法包括以下步骤:
(a)提供基于第一DNA聚合酶的N-末端域、掌域和指域和拇指域;
(b)提供基于第二DNA聚合酶的核酸外切酶域;
(c)结合来自步骤(a)和步骤(b)的域以形成嵌合聚合酶;
其中,所述嵌合聚合酶具有高于所述第二DNA聚合酶的持续合成能力、延伸率、抗盐性、热稳定性,以及高于所述第一DNA聚合酶的保真性。
本发明技术方案还提供了一种设计嵌合聚合酶的方法,其中第一DNA聚合酶选自KOD聚合酶。
本发明技术方案还提供了一种设计嵌合聚合酶的方法,其中第二DNA聚合酶是Pfu聚合酶。
本发明技术方案还提供了根据上述设计嵌合聚合酶的方法设计的嵌合聚合酶。
本发明技术方案还提供了一种改善DNA聚合酶的保真性的方法,该方法包括以下步骤:用PFU的DNA聚合酶的相应序列替代KOD的DNA聚合酶的N-末端域,核酸外切酶域,掌域,拇指域和指域内的序列,使得DNA聚合酶具有更高的保真性、抗盐性或热稳定性。
本发明技术方案还提供了一种改善DNA聚合酶的持续合成能力、延伸率、热稳定性的方法,该方法包括以下步骤:用KOD的DNA聚合酶的相应序列替代PFU的DNA聚合酶的N-末端域,核酸外切酶域,掌域,拇指域和指域内的序列,使得DNA聚合酶具有更高的持续合成能力、延伸率或PCR增强子抗性。
本发明还提供了使用上述改善DNA聚合酶的持续合成能力、延伸率、热稳定性的方法改进的DNA聚合酶。
附图说明
图1、为本发明其一个实施例中嵌合DNA聚合酶包含KOD聚合酶的N-末端域、3’-5’核酸外切酶域,拇指域,掌和指域,以及Pfu聚合酶的3’-5’核酸外切酶域;
图2、为本发明其一个实施例中嵌合DNA聚合酶电泳图;
图3、为本发明其中一个实施例中嵌合DNA聚合酶与KOD,Pfu的合成速率检测电泳图。
图4、为本发明其一个实施例中嵌合DNA聚合酶与KOD,Pfu热稳定性检测电泳图;
图5、为本发明其中一个实施例中嵌合DNA聚合酶与KOD,Pfu扩增能力检测电泳。
具体实施方式
下述的实施例是为了进一步说明本发明的一些优选实施例,并非全部实施例。本领域专业人员在没有进行创造性劳动的前提下做出的基于本发明的其他实施例,都属于本发明的权利保护范围。下面将结合附图对本发明作进一步的说明。
实施例1:嵌合DNA聚合酶的设计
Pfu和KOD具有非常不同的表型特征,尤其是,就延伸率、持续合成能力以及错误率而言,Pfu在所有热稳定性聚合酶中Pfu DNA聚合酶的错误几率最低,错误率约为2.0x10-6,KOD是具有高扩增能力的DNA聚合酶,扩增速度是Taq酶的2倍,Pfu酶的6倍,扩增产量较高(~300nts)(takagi et al.1997)。
因此,本实施例的嵌合的DNA聚合酶是这两种酶的嵌合组合,其呈现比Pfu更低的错误率(0.93×I0-6),并具有与KOD可比的持续合成能力和延伸率(分别为约300nt/s和106-138nt/s)。本发明提供的嵌合DNA聚合酶的核苷酸序列为SEQ ID No.3,具体是将KOD酶的N-末端域核苷酸序列(1-390&981-1104),掌域核苷酸序列(1107-1347&1500-1761),指域核苷酸序列(1350-1497)和拇指域核苷酸序列(1764-2322)与Pfu酶的3’5’核酸外切酶域核苷酸序列(393-978)的核苷酸序列构建到原核表达载体PET15b的NdeI/BamHI限制性酶切位点间,转入工程菌BL21(DE3)中,经培养后,获得表达菌株。
实施例2:嵌合DNA聚合酶的纯化
将获得的表达菌种1:100接种到LB培养基中,37℃,250rmp震荡培养到OD600=2.5时,加入0.1mM IPTG诱导表达,为了提高蛋白可溶性表达的比例,同时将培养温度降至16℃,低温诱导表达过夜(16h),5k转离心收菌。
1.破菌∶菌体总量与破菌缓冲液(50mM Tis-Hcl,pH 8.0)1∶10混合,即1g菌体加入10ml缓冲液,超声破菌。8000rpm离心30min收集上清。
2.将热变性缓冲液(25mM Tris,1mM EDTA,0.5%Tween20,pH8.0,)按1:1混合到超声完全的破菌液中,混匀后放入75℃水浴锅中变性30min,10000rpm离心20min收集上清。
3.NI柱纯化:将NI柱洗脱样品透析至Buffer A(20mM Tris,250mM NaCl,pH8.0)中,调节Buffer B(20mM Tris,250mM NaCl,500mM Imidazole,pH8.0)中咪唑的浓度进行梯度洗脱。
4.阴离子柱纯化:将NI柱洗脱的纯度较高的样品过离子柱,控核酸内外切酶残留及核酸残留。将NI柱洗脱样品透析至Buffer C(20mM Tris,1mM EDTA,pH8.0)中,调节Buffer D(20mM Tris,1mM EDTA,1M NaCl,Ph8.0)中盐离子的浓度进行梯度洗脱,获得洗脱样品即为新型嵌合高保真DNA聚合酶。将获得样品透析至保存体系10mMTris-Hcl,1mMDTT,0.001%Tween20,0.001%NP40,50%甘油,PH8.0),新型嵌合高保真DNA聚合酶电泳图如图1所示,其中泳道MK:Molecular weight marker;泳道SR:Final product(3μg,reduced);泳道SN:Final product(3μg,non-reduced)。
实施例3:嵌合DNA聚合酶的延伸速率检测
将本发明实施例1制得的嵌合高保真DNA聚合酶和Pfu DNA聚合酶与Kod DNA聚合酶以λDNA为模板进行扩增,扩增片段为3000bp。结果如图3所示:Lnae1为嵌合DNA聚合酶。
反应体系及程序如下:
实施例3:嵌合DNA聚合酶的保真性检测
1)扩增LacIZα基因,引物序列如下:
F:GTTTTCCCAGTCACGAC
R:GGTATCTTTATAGTCCTGTCG
2)内切酶酶切,获得线性化载体:
3)将获得基因与载体连接,并将连接产物转化至宿主菌DH5a表达,在含有x-gal和IPTG培养基上培养,数蓝白斑数量,计算保真度。
根据以下公式计算:
结果如下表所示:
白斑 蓝斑 总克隆数 错配率(x10<sup>-6</sup>)
Pfu 120 6020 6140 1.31
Kod 370 5950 6320 4.02
嵌合DNA聚合酶 85 5995 6080 0.93
实施例5:嵌合DNA聚合酶的热稳定性
将本发明实施例1制得的高保真DNA聚合酶和Pfu DNA聚合酶与Kod DNA聚合酶以λDNA为模板进行扩增,扩增片段为500bp。其中嵌合DNA聚合酶与Kod DNA聚合酶延伸时间为15s/kb,Pfu DNA聚合酶的延伸时间为60s/kb,结果如图4所示。
反应体系及程序如下:
实施例6:嵌合DNA聚合酶的扩增性能
将本发明实施例1制得的嵌合DNA聚合酶和Pfu DNA聚合酶与Kod DNA聚合酶以λDNA为模板进行扩增,扩增片段为4K-30K。其中嵌合DNA聚合酶与Kod DNA聚合酶延伸时间为15s/kb,Pfu DNA聚合酶的延伸时间为60s/kb,结果如图5所示。
上述的实施例是为了进一步说明本发明的一些优选实施例,并非全部实施例。本领域专业人员在没有进行创造性劳动的前提下做出的基于本发明的其他实施例,都属于本发明的权利保护范围。
序列表
<110> 吴江近岸蛋白质科技有限公司
<120> 一种新型嵌合DNA聚合酶及其制备方法
<130> 2018
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2408
<212> DNA
<213> Artificial Sequence
<220>
<221>
<223> KOD密码子优化的核苷酸序列
<400> 1
atgattctgg ataccgacta tatcacggaa gatggcaaac cggtgatacg tatttttaag 60
nnaaagagaa tggtgagttc aaaatcgagt acgaccgcac ttttgagcca tatttctacg 120
cgnnttactg aaggacgata gcgccattga agaagttaaa aaaatcaccg cagagcggca 180
tgggnnacag tggtaaccgt gaagagagtt gaaaaagtcc agaaaaaatt tttgggacga 240
cctgtannga agtgtggaaa ctttatttca ctcaccccca agatgttccg gctatacgtg 300
ataaaattnn cgcgaacatc cagcggtcat tgatatttac gaatatgata taccttttgc 360
caagcgttac nnctcatcga caaaggcctg gtgccgatgg aaggtgatga agaattaaaa 420
atgttggcat tcnngacatt gaaacacttt atcacgaggg ggaagagttt gctgagggtc 480
ccatcctgat gattnntctt atgcggatga agagggtgcc cgcgtaataa cctggaagaa 540
cgttgatctc ccgtacnngt ggacgtcgtt agtacggaac gggaaatgat caaacgtttc 600
ctgcgcgtag tgaaagagnn aaagatccag acgtcttaat tacctataat ggtgataact 660
ttgattttgc atacctgaaa nnaaaagatg cgaaaagttg ggcataaatt tcgctcttgg 720
tcgagacggg tcagagccta aannatccag cgtatgggag atcgctttgc ggttgaagtg 780
aaaggccgga ttcatttcga cctgnntatc cggtaattcg tcgcactatc aacctcccca 840
catacacgtt agaagccgtc tatgagnngc agtttttggt caaccgaagg aaaaagttta 900
cgctgaggaa attaccactg cgtgggaann acaggcgaga atctggaacg tgtagcccgc 960
tattctatgg aggatgcaaa agttacctat nngaattggg taaggaattt cttccaatgg 1020
aggcgcagct gtcgagatta atagggcaga gcnnctgtgg gacgtgtctc gaagttcaac 1080
gggaaacctc gtcgaatggt ttctgttgcg gaaanngcat acgagcgtaa tgaacttgcc 1140
cctaacaaac cggatgaaaa ggagctggca cgccgtnncg ccaatcctat gaaggcggtt 1200
acgttaaaga accagagcgg gggttatggg aaaatatcnn gtgtatctgg atttccgttc 1260
gctctacccg agcattatca ttacccacaa cgtatctccc nngacacttt gaatcgcgag 1320
ggctgtaaag aatatgatgt cgcgccgcag gttggtcata gannttttgc aaggacttcc 1380
cgggatttat accaagtctg cttggcgatt tactggaaga gcganncaaa aaatcaaaaa 1440
gaaaatgaaa gctacaatcg atccgataga acgtaagctg ctcgacnnta ccgccagcgg 1500
gccatcaaaa ttttggcaaa ctcatattat ggttactatg ggtacgcgnn cgtgctcgct 1560
ggtattgtaa agagtgcgcc gaatccgtga cggcatgggg ccgtgaatac nnatcaccat 1620
gactattaag gagatagaag agaaatatgg tttcaaagta atctactcgg atnnacagac 1680
ggattctttg cgacgattcc cggtgccgat gcagaaaccg tcaagaaaaa agcgnnatgg 1740
aattccttaa gtatataaat gctaaattac ctggtgccct ggagctggaa tacgaanngg 1800
gttttacaaa cgcggattct ttgttactaa gaaaaaatat gcggtgatcg acgaggaann 1860
ggcaagatta cgaccagagg cctcgagatt gtacggcgtg attggagcga aatcgctaaa 1920
nngaaacaca ggcacgtgtc ttggaggcat tactgaaaga tggggacgtt gaaaaggcgg 1980
tgnncgaatt gtaaaagaag tcaccgaaaa actttctaag tacgaagttc cgccagagaa 2040
actgnngtga tacacgaaca aatcactcgt gatctgaaag actataaggc tacaggcccg 2100
catgtanngc agtcgccaaa cgcctcgcgg ctcggggtgt taaaattcgt cccggaacgg 2160
tgatcagtcn acnannntac attgtattga agggctcagg tcgcataggg gatagagcaa 2220
tccctttcga cgagtttnng atccaaccaa acacaaatat gatgccgaat actatattga 2280
aaaccaggtc ttgccggcgn ngttgagcgt atactgcgcg ctttcggcta tcgaaaggaa 2340
gatcttcgtt accaaaaaac tnnagacagg tgggtctgtc cgcatggctc aaacctaagg 2400
gaacgtaa 2408
<210> 2
<211> 2403
<212> DNA
<213> Artificial Sequence
<220>
<221>
<223>Pfu 密码子优化的核苷酸序列
<400> 2
atgattctgg atgtggacta tatcaccgaa gagggcaaac cggttatacg tttatttaag 60
nnaaagagaa tggtaaattc aagatcgagc atgaccgcac gttcggtcca tacatttacg 120
cgnnttgctt cgggatgata gcaaaattga ggaagtcaaa aagatcaccg gggaacgtca 180
tggannaaaa tagtaagaat tgtggacgtt gaaaaagtcg aaaagaaatt tctgggcaaa 240
ccgatcnnac tgtatggaag ctctatctgg aacatcctca ggatgtgccc acaattcgag 300
aaaaagttnn cgtgagcacc cagccgtcgt ggatatattt gaatatgaca tcccttttgc 360
aaaacgctac nnttaattga taaaggcctg atcccgatgg agggggaaga agaacttaaa 420
attctggctt ttnngacata gaaacgctct atcatgaggg agaagaattt ggcaaaggtc 480
ccatcattat gattnntctt acgcggatga gaacgaagcc aaggtaatca cttggaaaaa 540
tattgacctg ccgtacnngt tgaagtggtc agttcagagc gggaaatgat taaacgtttt 600
ttacgcatca ttagagagnn aaagatccag atataatcgt tacatataac ggcgactcct 660
tcgattttcc ttacctggca nnaaacgagc tgaaaaattg ggtattaaac ttaccatcgg 720
gcgtgacgga tcggaaccga aannatgcaa cgcattggcg atatgacggc ggtagaggtg 780
aaaggtcgga tacactttga tctgnntatc atgtcatcac ccgtactatt aatctcccca 840
catacacgtt agaagccgtt tatgagnngc aatattcggc aagccgaaag aaaaagtgta 900
cgctgacgaa atcgcgaagg catgggagnn agcggcgaaa acctggagcg cgtagcaaaa 960
tattctatgg aagatgctaa agcgacctac nngaattggg gaaagaattt cttccaatgg 1020
aaattcagct gagtcgttta gtcggacaac ctnnctgtgg gacgtttcac gctcctcgac 1080
tggcaatctc gtggagtggt tcctgttgag aaaanngcct atgaacgaaa cgaagtagca 1140
ccgaataaac caagcgagga agaatatcag cgtcgcnnct tcgcgagtct tacacaggtg 1200
ggtttgttaa ggaaccggag aaaggtcttt gggaaaacnn atcgtgtatt tagatttccg 1260
tgcgctgtac cccagtatta taatcaccca caatgtctca nncctgacac gctcaacttg 1320
gaaggttgca aaaattatga tattgctccg caagttggac atnnaagttt tgtaaagata 1380
ttccgggctt catcccgtcc ctgcttggtc acttactgga agagnncgcc aaaaaattaa 1440
gaccaaaatg aaagagactc aggatcccat tgaaaagatc ctgctcnnga ttaccggcaa 1500
aaagccatta aattgcttgc aaactcgttt tatgggtact atggctatnn gcgaaggctc 1560
gttggtactg caaagaatgt gccgagagcg tgacagcatg gggtcgcaaa nntatataga 1620
attagtatgg aaggagctgg aagaaaattc ggattcaaag tcctgtacat cnngatacgg 1680
atggcctcta tgcgaccatt cctggtgggg agtctgaaga aatcaagaaa aaanngcctt 1740
ggaattcgtt aagtacatta atagtaaatt accgggactg cttgaactgg agtatnngaa 1800
ggcttctaca aaagaggttt tttcgttact aagaaacgat atgccgtaat agatgaanng 1860
aggggaaagt catcacacgt ggcctcgaga ttgttcgccg ggactggtca gagatagcan 1920
naaggaaacg caggcgcgcg tgctcgaaac catcttgaaa catggtgatg tagaggaagc 1980
cnngtccgca ttgttaaaga ggtgatccag aagttagcaa actatgaaat tccaccggaa 2040
aaannctggc gatatacgag caaatcactc gtccccttca cgaatataaa gctattggac 2100
ctcatnngta gccgtcgcga agaaactggc tgcaaaaggc gttaagataa aaccaggtat 2160
ggtgatcnng ggtacattgt actccgcggc gacggtccga tttccaatag agccatcttg 2220
gcggaggaan ntatgatcct aaaaagcata aatacgacgc tgaatattac attgagaacc 2280
aggtcttgcc gnngcagttc tgcggatact tgaaggattt ggctatcgta aagaagatct 2340
gcgctatcaa aagnnacgcg acaggtgggt ctgactagct ggttgaatat caaaaaatcg 2400
taa 2403
<210> 3
<211> 2325
<212> DNA
<213> Artificial Sequence
<220>
<221>
<223>嵌合DNA聚合酶的核苷酸序列
<400> 3
atgattctgg ataccgatta tattaccgaa gatggcaaac cggtgattcg catttttaaa 60
aaagaaaacg gcgaatttaa aattgaatat gatcgcacct ttgaaccgta tttttatgcg 120
ctgctgaaag atgatagcgc gattgaagaa gtgaaaaaaa ttaccgcgga acgccatggc 180
accgtggtga ccgtgaaacg cgtggaaaaa gtgcagaaaa aatttctggg ccgcccggtg 240
gaagtgtgga aactgtattt tacccatccg caggatgtgc cggcgattcg cgataaaatt 300
cgcgaacatc cggcggtgat tgatatttat gaatatgata ttccgtttgc gaaacgctat 360
ctgattgata aaggcctggt gccgatggaa ggggaagaag agctaaagat tcttgccttc 420
gatatagaaa ccctctatca cgaaggagaa gagtttggaa aaggcccaat tataatgatt 480
agttatgcag atgaaaatga agcaaaggtg attacttgga aaaacataga tcttccatac 540
gttgaggttg tatcaagcga gagagagatg ataaagagat ttctcaggat tatcagggag 600
aaggatcctg acattatagt tacttataat ggagactcat tcgacttccc atatttagcg 660
aaaagggcag aaaaacttgg gattaaatta accattggaa gagatggaag cgagcccaag 720
atgcagagaa taggcgatat gacggctgta gaagtcaagg gaagaataca tttcgacttg 780
tatcatgtaa taacaaggac aataaatctc ccaacataca cactagaggc tgtatatgaa 840
gcaatttttg gaaagccaaa ggagaaggta tacgccgacg agatagcaaa agcctgggaa 900
agtggagaga accttgagag agttgccaaa tactcgatgg aagatgcaaa ggcaacttat 960
gaactcggga aagaattcct gccgatggaa gcgcagctga gccgcctgat tggccagagc 1020
ctgtgggatg tgagccgcag cagcaccggc aacctggtgg aatggtttct gctgcgcaaa 1080
gcgtatgaac gcaacgaact ggcgccgaac aaaccggatg aaaaagaact ggcgcgccgc 1140
cgccagagct atgaaggcgg ctatgtgaaa gaaccggaac gcggcctgtg ggaaaacatt 1200
gtgtatctgg attttcgcag cctgtatccg agcattatta ttacccataa cgtgagcccg 1260
gataccctga accgcgaagg ctgcaaagaa tatgatgtgg cgccgcaggt gggccatcgc 1320
ttttgcaaag attttccggg ctttattccg agcctgctgg gcgatctgct ggaagaacgc 1380
cagaaaatta aaaaaaaaat gaaagcgacc attgatccga ttgaacgcaa actgctggat 1440
tatcgccagc gcgcgattaa aattctggcg aacagctatt atggctatta tggctatgcg 1500
cgcgcgcgct ggtattgcaa agaatgcgcg gaaagcgtga ccgcgtgggg ccgcgaatat 1560
attaccatga ccattaaaga aattgaagaa aaatatggct ttaaagtgat ttatagcgat 1620
accgatggct tttttgcgac cattccgggc gcggatgcgg aaaccgtgaa aaaaaaagcg 1680
atggaatttc tgaaatatat taacgcgaaa ctgccgggcg cgctggaact ggaatatgaa 1740
ggcttttatg aacgcggctt ttttgtgacc aaaaaaaaat atgcggtgat tgatgaagaa 1800
ggcaaaatta ccacccgcgg cctggaaatt gtgcgccgcg attggagcga aattgcgaaa 1860
gaaacccagg cgcgcgtgct ggaagcgctg ctgaaagatg gcgatgtgga aaaagcggtg 1920
cgcattgtga aagaagtgac cgaaaaactg agcaaatatg aagtgccgcc ggaaaaactg 1980
gtgattcatg aacagattac ccgcgatctg aaagattata aagcgaccgg cccgcatgtg 2040
gcggtggcga aacgcctggc ggcgcgcggc gtgaaaattc gcccgggcac cgtgattagc 2100
tatattgtgc tgaaaggcag cggccgcatt ggcgatcgcg cgattccgtt tgatgaattt 2160
gatccgacca aacataaata tgatgcggaa tattatattg aaaaccaggt gctgccggcg 2220
gtggaacgca ttctgcgcgc gtttggctat cgcaaagaag atctgcgcta tcagaaaacc 2280
cgccaggtgg gcctgagcgc gtggctgaaa ccgaaaggca cctga 2325
<210> 4
<211> 798
<212> PRT
<213> Artificial Sequence
<220>
<221>
<223>KOD氨基酸序列
<400> 4
Met Ile Leu Asp Thr Asp Tyr Ile Thr Glu Asp Gly Lys Pro Val Ile
1 5 10 15
Arg Ile Phe Lys Lys Glu Asn Gly Glu Phe Lys Ile Glu Tyr Asp Arg
20 25 30
Thr Phe Glu Pro Tyr Phe Tyr Ala Leu Leu Lys Asp Asp Ser Ala Ile
35 40 45
Glu Glu Val Lys Lys Ile Thr Ala Glu Arg His Gly Xaa Xaa Thr Val
50 55 60
Val Thr Val Lys Arg Val Glu Lys Val Gln Lys Lys Phe Leu Gly Arg
65 70 75 80
Pro Val Glu Val Trp Lys Leu Tyr Phe Thr His Pro Gln Asp Val Pro
85 90 95
Ala Ile Arg Asp Lys Ile Arg Glu His Pro Ala Val Ile Asp Ile Tyr
100 105 110
Glu Tyr Asp Ile Pro Phe Ala Lys Arg Tyr Xaa Xaa Leu Ile Asp Lys
115 120 125
Gly Leu Val Pro Met Glu Gly Asp Glu Glu Leu Lys Met Leu Ala Phe
130 135 140
Asp Ile Glu Thr Leu Tyr His Glu Gly Glu Glu Phe Ala Glu Gly Pro
145 150 155 160
Ile Leu Met Ile Ser Tyr Ala Asp Glu Glu Gly Ala Arg Val Ile Thr
165 170 175
Trp Lys Asn Val Asp Leu Pro Tyr Xaa Xaa Val Asp Val Val Ser Thr
180 185 190
Glu Arg Glu Met Ile Lys Arg Phe Leu Arg Val Val Lys Glu Lys Asp
195 200 205
Pro Asp Val Leu Ile Thr Tyr Asn Gly Asp Asn Phe Asp Phe Ala Tyr
210 215 220
Leu Lys Lys Arg Cys Glu Lys Leu Gly Ile Asn Phe Ala Leu Gly Arg
225 230 235 240
Asp Gly Ser Glu Pro Lys Xaa Xaa Ile Gln Arg Met Gly Asp Arg Phe
245 250 255
Ala Val Glu Val Lys Gly Arg Ile His Phe Asp Leu Tyr Pro Val Ile
260 265 270
Arg Arg Thr Ile Asn Leu Pro Thr Tyr Thr Leu Glu Ala Val Tyr Glu
275 280 285
Ala Val Phe Gly Gln Pro Lys Glu Lys Val Tyr Ala Glu Glu Ile Thr
290 295 300
Thr Ala Trp Glu Xaa Xaa Thr Gly Glu Asn Leu Glu Arg Val Ala Arg
305 310 315 320
Tyr Ser Met Glu Asp Ala Lys Val Thr Tyr Glu Leu Gly Lys Glu Phe
325 330 335
Leu Pro Met Glu Ala Gln Leu Ser Arg Leu Ile Gly Gln Ser Leu Trp
340 345 350
Asp Val Ser Arg Ser Ser Thr Gly Asn Leu Val Glu Trp Phe Leu Leu
355 360 365
Arg Lys Xaa Xaa Ala Tyr Glu Arg Asn Glu Leu Ala Pro Asn Lys Pro
370 375 380
Asp Glu Lys Glu Leu Ala Arg Arg Arg Gln Ser Tyr Glu Gly Gly Tyr
385 390 395 400
Val Lys Glu Pro Glu Arg Gly Leu Trp Glu Asn Ile Val Tyr Leu Asp
405 410 415
Phe Arg Ser Leu Tyr Pro Ser Ile Ile Ile Thr His Asn Val Ser Pro
420 425 430
Xaa Xaa Asp Thr Leu Asn Arg Glu Gly Cys Lys Glu Tyr Asp Val Ala
435 440 445
Pro Gln Val Gly His Arg Phe Cys Lys Asp Phe Pro Gly Phe Ile Pro
450 455 460
Ser Leu Leu Gly Asp Leu Leu Glu Glu Arg Gln Lys Ile Lys Lys Lys
465 470 475 480
Met Lys Ala Thr Ile Asp Pro Ile Glu Arg Lys Leu Leu Asp Xaa Xaa
485 490 495
Tyr Arg Gln Arg Ala Ile Lys Ile Leu Ala Asn Ser Tyr Tyr Gly Tyr
500 505 510
Tyr Gly Tyr Ala Arg Ala Arg Trp Tyr Cys Lys Glu Cys Ala Glu Ser
515 520 525
Val Thr Ala Trp Gly Arg Glu Tyr Ile Thr Met Thr Ile Lys Glu Ile
530 535 540
Glu Glu Lys Tyr Gly Phe Lys Val Ile Tyr Ser Asp Xaa Xaa Thr Asp
545 550 555 560
Gly Phe Phe Ala Thr Ile Pro Gly Ala Asp Ala Glu Thr Val Lys Lys
565 570 575
Lys Ala Met Glu Phe Leu Lys Tyr Ile Asn Ala Lys Leu Pro Gly Ala
580 585 590
Leu Glu Leu Glu Tyr Glu Gly Phe Tyr Lys Arg Gly Phe Phe Val Thr
595 600 605
Lys Lys Lys Tyr Ala Val Ile Asp Glu Glu Xaa Xaa Gly Lys Ile Thr
610 615 620
Thr Arg Gly Leu Glu Ile Val Arg Arg Asp Trp Ser Glu Ile Ala Lys
625 630 635 640
Glu Thr Gln Ala Arg Val Leu Glu Ala Leu Leu Lys Asp Gly Asp Val
645 650 655
Glu Lys Ala Val Arg Ile Val Lys Glu Val Thr Glu Lys Leu Ser Lys
660 665 670
Tyr Glu Val Pro Pro Glu Lys Leu Xaa Xaa Val Ile His Glu Gln Ile
675 680 685
Thr Arg Asp Leu Lys Asp Tyr Lys Ala Thr Gly Pro His Val Ala Val
690 695 700
Ala Lys Arg Leu Ala Ala Arg Gly Val Lys Ile Arg Pro Gly Thr Val
705 710 715 720
Ile Ser Tyr Ile Val Leu Lys Gly Ser Gly Arg Ile Gly Asp Arg Ala
725 730 735
Ile Pro Phe Asp Glu Phe Xaa Xaa Asp Pro Thr Lys His Lys Tyr Asp
740 745 750
Ala Glu Tyr Tyr Ile Glu Asn Gln Val Leu Pro Ala Val Glu Arg Ile
755 760 765
Leu Arg Ala Phe Gly Tyr Arg Lys Glu Asp Leu Arg Tyr Gln Lys Thr
770 775 780
Arg Gln Val Gly Leu Ser Ala Trp Leu Lys Pro Lys Gly Thr
785 790 795
<210> 5
<211> 799
<212> PRT
<213> Artificial Sequence
<220>
<221>
<223>Pfu 氨基酸序列
<400> 5
Met Ile Leu Asp Val Asp Tyr Ile Thr Glu Glu Gly Lys Pro Val Ile
1 5 10 15
Arg Leu Phe Lys Lys Glu His Gly Lys Phe Lys Ile Glu His Asp Arg
20 25 30
Thr Phe Arg Pro Tyr Ile Tyr Ala Leu Leu Arg Asp Asp Ser Lys Ile
35 40 45
Glu Glu Val Lys Lys Ile Thr Gly Glu Arg His Gly Xaa Xaa Lys Ile
50 55 60
Val Arg Ile Val Asp Val Glu Lys Val Glu Lys Lys Phe Leu Gly Lys
65 70 75 80
Pro Ile Thr Val Lys Lys Leu Tyr Leu Glu His Pro Gln Asp Val Pro
85 90 95
Thr Ile Arg Glu Lys Val Arg Glu His Pro Ala Val Val Asp Ile Phe
100 105 110
Glu Tyr Asp Ile Pro Phe Ala Lys Arg Tyr Xaa Xaa Leu Ile Asp Lys
115 120 125
Gly Leu Ile Pro Met Glu Gly Glu Glu Glu Leu Lys Ile Leu Ala Phe
130 135 140
Asp Ile Glu Thr Leu Tyr His Glu Gly Glu Glu Phe Gly Lys Gly Pro
145 150 155 160
Ile Ile Met Ile Ser Tyr Ala Asp Glu His Glu Ala Lys Val Ile Thr
165 170 175
Trp Lys His Ile Asp Leu Pro Tyr Xaa Xaa Val Glu Val Val Ser Ser
180 185 190
Glu Arg Glu Asn Ile Lys Arg Phe Leu Arg Ile Ile Arg Glu Lys Asp
195 200 205
Pro Asp Ile Ile Val Thr Tyr His Gly Asp Ser Phe Asp Phe Pro Tyr
210 215 220
Leu Ala Lys Arg Ala Glu Lys Leu Gly Ile Lys Leu Thr Ile Gly Arg
225 230 235 240
Asp Gly Ser Glu Pro Lys Xaa Xaa Met Gln Arg Ile Gly Asp Met Thr
245 250 255
Ala Val Glu Val Lys Gly Arg Ile His Phe Asp Leu Tyr His Val Ile
260 265 270
Thr Arg Thr Ile His Leu Pro Thr Tyr Thr Leu Glu Ala Val Tyr Glu
275 280 285
Ala Ile Phe Gly Lys Pro Lys Glu Lys Val Tyr Ala Asp Glu Ile Ala
290 295 300
Lys Ala Trp Glu Xaa Xaa Ser Gly Glu His Leu Glu Arg Val Ala Lys
305 310 315 320
Tyr Ser Asn Glu Asp Ala Lys Ala Thr Tyr Glu Leu Gly Lys Glu Phe
325 330 335
Leu Pro Met Glu Ile Gln Leu Ser Arg Leu Val Gly Gln Pro Leu Trp
340 345 350
Asp Val Ser Arg Ser Ser Thr Gly Asn Leu Val Glu Trp Phe Leu Leu
355 360 365
Arg Lys Xaa Xaa Ala Tyr Glu Arg Asn Glu Val Ala Pro His Lys Pro
370 375 380
Ser Glu Glu Glu Tyr Gln Arg Arg Leu Arg Glu Ser Tyr Thr Gly Gly
385 390 395 400
Phe Val Lys Glu Pro Glu Lys Gly Leu Trp Glu His Ile Val Tyr Leu
405 410 415
Asp Phe Arg Ala Leu Tyr Pro Ser Ile Ile Ile Thr His Asn Val Ser
420 425 430
Xaa Xaa Pro Asp Thr Leu His Leu Glu Gly Cys Lys Asn Tyr Asp Ile
435 440 445
Ala Pro Gln Val Gly His Lys Phe Cys Lys Asp Ile Pro Gly Phe Ile
450 455 460
Pro Ser Leu Leu Gly His Leu Leu Glu Glu Arg Gln Lys Ile Lys Thr
465 470 475 480
Lys Met Lys Glu Thr Gln Asp Pro Ile Glu Lys Ile Leu Leu Xaa Xaa
485 490 495
Asp Tyr Arg Gln Lys Ala Ile Lys Leu Leu Ala His Ser Phe Tyr Gly
500 505 510
Tyr Tyr Gly Tyr Ala Lys Ala Arg Trp Tyr Cys Lys Glu Cys Ala Glu
515 520 525
Ser Val Thr Ala Trp Gly Arg Lys Tyr Ile Glu Leu Val Trp Lys Glu
530 535 540
Leu Glu Glu Lys Phe Gly Phe Lys Val Leu Tyr Ile Xaa Xaa Asp Thr
545 550 555 560
Asp Gly Leu Tyr Ala Thr Ile Pro Gly Gly Glu Ser Glu Glu Ile Lys
565 570 575
Lys Lys Ala Leu Glu Phe Val Lys Tyr Ile His Ser Lys Leu Pro Gly
580 585 590
Leu Leu Glu Leu Glu Tyr Glu Gly Phe Tyr Lys Arg Gly Phe Phe Val
595 600 605
Thr Lys Lys Arg Tyr Ala Val Ile Asp Glu Xaa Xaa Glu Gly Lys Val
610 615 620
Ile Thr Arg Gly Leu Glu Ile Val Arg Arg Asp Trp Ser Glu Ile Ala
625 630 635 640
Lys Glu Thr Gln Ala Arg Val Leu Glu Thr Ile Leu Lys His Gly Asp
645 650 655
Val Glu Glu Ala Val Arg Ile Val Lys Glu Val Ile Gln Lys Leu Ala
660 665 670
His Tyr Glu Ile Pro Pro Glu Lys Xaa Xaa Leu Ala Ile Tyr Glu Gln
675 680 685
Ile Thr Arg Pro Leu His Glu Tyr Lys Ala Ile Gly Pro His Val Ala
690 695 700
Val Ala Lys Lys Leu Ala Ala Lys Gly Val Lys Ile Lys Pro Gly Met
705 710 715 720
Val Ile Gly Tyr Ile Val Leu Arg Gly Asp Gly Pro Ile Ser His Arg
725 730 735
Ala Ile Leu Ala Glu Glu Xaa Xaa Tyr Asp Pro Lys Lys His Lys Tyr
740 745 750
Asp Ala Glu Tyr Tyr Ile Glu Asn Gln Val Leu Pro Ala Val Leu Arg
755 760 765
Ile Leu Glu Gly Phe Gly Tyr Arg Lys Glu Asp Leu Arg Tyr Gln Lys
770 775 780
Thr Arg Gln Val Gly Leu Thr Ser Trp Leu Asn Ile Lys Lys Ser
785 790 795
<210> 6
<211> 774
<212> PRT
<213> Artificial Sequence
<220>
<221>
<223>嵌合DNA聚合酶的氨基酸序列
<400> 6
Met Ile Leu Asp Thr Asp Tyr Ile Thr Glu Asp Gly Lys Pro Val Ile
1 5 10 15
Arg Ile Phe Lys Lys Glu Asn Gly Glu Phe Lys Ile Glu Tyr Asp Arg
20 25 30
Thr Phe Glu Pro Tyr Phe Tyr Ala Leu Leu Lys Asp Asp Ser Ala Ile
35 40 45
Glu Glu Val Lys Lys Ile Thr Ala Glu Arg His Gly Thr Val Val Thr
50 55 60
Val Lys Arg Val Glu Lys Val Gln Lys Lys Phe Leu Gly Arg Pro Val
65 70 75 80
Glu Val Trp Lys Leu Tyr Phe Thr His Pro Gln Asp Val Pro Ala Ile
85 90 95
Arg Asp Lys Ile Arg Glu His Pro Ala Val Ile Asp Ile Tyr Glu Tyr
100 105 110
Asp Ile Pro Phe Ala Lys Arg Tyr Leu Ile Asp Lys Gly Leu Val Pro
115 120 125
Met Glu Gly Glu Glu Glu Leu Lys Ile Leu Ala Phe Asp Ile Glu Thr
130 135 140
Leu Tyr His Glu Gly Glu Glu Phe Gly Lys Gly Pro Ile Ile Met Ile
145 150 155 160
Ser Tyr Ala Asp Glu Asn Glu Ala Lys Val Ile Thr Trp Lys Asn Ile
165 170 175
Asp Leu Pro Tyr Val Glu Val Val Ser Ser Glu Arg Glu Met Ile Lys
180 185 190
Arg Phe Leu Arg Ile Ile Arg Glu Lys Asp Pro Asp Ile Ile Val Thr
195 200 205
Tyr Asn Gly Asp Ser Phe Asp Phe Pro Tyr Leu Ala Lys Arg Ala Glu
210 215 220
Lys Leu Gly Ile Lys Leu Thr Ile Gly Arg Asp Gly Ser Glu Pro Lys
225 230 235 240
Met Gln Arg Ile Gly Asp Met Thr Ala Val Glu Val Lys Gly Arg Ile
245 250 255
His Phe Asp Leu Tyr His Val Ile Thr Arg Thr Ile Asn Leu Pro Thr
260 265 270
Tyr Thr Leu Glu Ala Val Tyr Glu Ala Ile Phe Gly Lys Pro Lys Glu
275 280 285
Lys Val Tyr Ala Asp Glu Ile Ala Lys Ala Trp Glu Ser Gly Glu Asn
290 295 300
Leu Glu Arg Val Ala Lys Tyr Ser Met Glu Asp Ala Lys Ala Thr Tyr
305 310 315 320
Glu Leu Gly Lys Glu Phe Leu Pro Met Glu Ala Gln Leu Ser Arg Leu
325 330 335
Ile Gly Gln Ser Leu Trp Asp Val Ser Arg Ser Ser Thr Gly Asn Leu
340 345 350
Val Glu Trp Phe Leu Leu Arg Lys Ala Tyr Glu Arg Asn Glu Leu Ala
355 360 365
Pro Asn Lys Pro Asp Glu Lys Glu Leu Ala Arg Arg Arg Gln Ser Tyr
370 375 380
Glu Gly Gly Tyr Val Lys Glu Pro Glu Arg Gly Leu Trp Glu Asn Ile
385 390 395 400
Val Tyr Leu Asp Phe Arg Ser Leu Tyr Pro Ser Ile Ile Ile Thr His
405 410 415
Asn Val Ser Pro Asp Thr Leu Asn Arg Glu Gly Cys Lys Glu Tyr Asp
420 425 430
Val Ala Pro Gln Val Gly His Arg Phe Cys Lys Asp Phe Pro Gly Phe
435 440 445
Ile Pro Ser Leu Leu Gly Asp Leu Leu Glu Glu Arg Gln Lys Ile Lys
450 455 460
Lys Lys Met Lys Ala Thr Ile Asp Pro Ile Glu Arg Lys Leu Leu Asp
465 470 475 480
Tyr Arg Gln Arg Ala Ile Lys Ile Leu Ala Asn Ser Tyr Tyr Gly Tyr
485 490 495
Tyr Gly Tyr Ala Arg Ala Arg Trp Tyr Cys Lys Glu Cys Ala Glu Ser
500 505 510
Val Thr Ala Trp Gly Arg Glu Tyr Ile Thr Met Thr Ile Lys Glu Ile
515 520 525
Glu Glu Lys Tyr Gly Phe Lys Val Ile Tyr Ser Asp Thr Asp Gly Phe
530 535 540
Phe Ala Thr Ile Pro Gly Ala Asp Ala Glu Thr Val Lys Lys Lys Ala
545 550 555 560
Met Glu Phe Leu Lys Tyr Ile Asn Ala Lys Leu Pro Gly Ala Leu Glu
565 570 575
Leu Glu Tyr Glu Gly Phe Tyr Glu Arg Gly Phe Phe Val Thr Lys Lys
580 585 590
Lys Tyr Ala Val Ile Asp Glu Glu Gly Lys Ile Thr Thr Arg Gly Leu
595 600 605
Glu Ile Val Arg Arg Asp Trp Ser Glu Ile Ala Lys Glu Thr Gln Ala
610 615 620
Arg Val Leu Glu Ala Leu Leu Lys Asp Gly Asp Val Glu Lys Ala Val
625 630 635 640
Arg Ile Val Lys Glu Val Thr Glu Lys Leu Ser Lys Tyr Glu Val Pro
645 650 655
Pro Glu Lys Leu Val Ile His Glu Gln Ile Thr Arg Asp Leu Lys Asp
660 665 670
Tyr Lys Ala Thr Gly Pro His Val Ala Val Ala Lys Arg Leu Ala Ala
675 680 685
Arg Gly Val Lys Ile Arg Pro Gly Thr Val Ile Ser Tyr Ile Val Leu
690 695 700
Lys Gly Ser Gly Arg Ile Gly Asp Arg Ala Ile Pro Phe Asp Glu Phe
705 710 715 720
Asp Pro Thr Lys His Lys Tyr Asp Ala Glu Tyr Tyr Ile Glu Asn Gln
725 730 735
Val Leu Pro Ala Val Glu Arg Ile Leu Arg Ala Phe Gly Tyr Arg Lys
740 745 750
Glu Asp Leu Arg Tyr Gln Lys Thr Arg Gln Val Gly Leu Ser Ala Trp
755 760 765
Leu Lys Pro Lys Gly Thr
770

Claims (20)

1.一种新型的嵌合DNA聚合酶,其特征在于:所述嵌合DNA聚合酶包含第一域和第二域,
所述第一域取自第一DNA聚合酶中的氨基酸序列,所述第一DNA聚合酶的特征在于延伸率、高持续合成能力、热稳定性;
所述第二域取自第二DNA聚合酶中的氨基酸序列,所述第二DNA聚合酶的特征在于高保真性;所述嵌合DNA聚合酶的特征在于高保真性和高持续合成能力、延伸率、热稳定性。
2.根据权利要求1所述的嵌合聚合酶,其特征在于,所述第一DNA聚合酶选自KOD聚合酶。
3.根据权利要求1所述的嵌合聚合酶,其特征在于,所述第二DNA聚合酶选自Pfu聚合酶。
4.根据权利要求1所述的嵌合聚合酶,其特征在于,所述一个DNA聚合酶是KOD聚合酶,而所述另一个DNA聚合酶是Pfu聚合酶。
5.根据权利要求1~4中任一项所述的嵌合聚合酶,其特征在于,所述第一域选自N-末端域、拇指域以及掌域和指域。
6.根据权利要求5所述的嵌合聚合酶,其特征在于,所述第二域是核酸外切酶域。
7.根据权利要求6所述的嵌合聚合酶,其特征在于,所述第一DNA聚合酶中所述氨基酸序列对应于KOD聚合酶(SEQ ID No.4)的氨基酸残基N-末端域,掌域,指域和拇指域。
8.根据权利要求7所述的嵌合聚合酶,其特征在于,在所述第二DNA聚合酶中所述氨基酸序列对应于Pfu聚合酶(SEQ ID No.5)的氨基酸残基核酸外切酶域。
9.根据权利要求8所述的嵌合聚合酶,其特征在于,所述的嵌合聚合酶的氨基酸序列相同于SEQ ID No.6,其中,所述嵌合聚合酶具有高于KOD的保真性以及高于Pfu的持续合成能力、延伸率和热稳定性。
10.一种嵌合聚合酶,其特征在于,所述嵌合聚合酶包括第一域和第二域,
所述第一域,取第一DNA聚合酶中的氨基酸序列N-末端域、拇指域以及掌域和指域;
所述第二域,取自第二DNA聚合酶中的氨基酸序列核酸外切酶域,其中,所述嵌合聚合酶具有高于所述第二DNA聚合酶的持续合成能力、延伸率、热稳定性,以及高于所述第一DNA聚合酶的保真性。
11.根据权利要求10所述的一种嵌合聚合酶,其特征在于,包括至少80%相同于SEQ IDNo.6的氨基酸序列。
12.一种核苷酸序列,其特征在于,所述核苷酸序列编码根据权利要求1~11中任一项所述的嵌合聚合酶编码。
13.一种DNA合成的方法,其特征在于,所述DNA合成的方法使用权利要求1~12中任一项所述的嵌合聚合酶进行DNA合成的方法。
14.一种设计嵌合聚合酶的方法,其特征在于,所述方法包括以下步骤:
(a)提供基于第一DNA聚合酶的N-末端域、掌域和指域和拇指域;
(b)提供基于第二DNA聚合酶的核酸外切酶域;
(c)结合来自步骤(a)和步骤(b)的域以形成嵌合聚合酶;
其中,所述嵌合聚合酶具有高于所述第二DNA聚合酶的持续合成能力、延伸率、抗盐性、热稳定性,以及高于所述第一DNA聚合酶的保真性。
15.根据权利要求14所述的设计嵌合聚合酶的方法,其特征在于,所述第一DNA聚合酶选自KOD聚合酶。
16.根据权利要求14所述的设计嵌合聚合酶的方法,其特征在于,所述第二DNA聚合酶是Pfu聚合酶。
17.一种利用根据权利要求14~16中任一项所述的方法设计的嵌合聚合酶。
18.一种改善DNA聚合酶的保真性的方法,其特征在于,所述方法包括以下步骤:用PFU的DNA聚合酶的相应序列替代KOD的DNA聚合酶的N-末端域,核酸外切酶域,掌域,拇指域和指域内的序列,使得DNA聚合酶具有更高的保真性、抗盐性或热稳定性。
19.一种改善DNA聚合酶的持续合成能力、延伸率、热稳定性的方法,其特征在于,所述方法包括以下步骤:用KOD的DNA聚合酶的相应序列替代PFU的DNA聚合酶的N-末端域,核酸外切酶域,掌域,拇指域和指域内的序列,使得DNA聚合酶具有更高的持续合成能力、延伸率或PCR增强子抗性。
20.根据权利要求18或19所述的方法的改进的DNA聚合酶。
CN201811651584.3A 2018-12-31 2018-12-31 一种新型嵌合dna聚合酶及其制备方法 Active CN109628424B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811651584.3A CN109628424B (zh) 2018-12-31 2018-12-31 一种新型嵌合dna聚合酶及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811651584.3A CN109628424B (zh) 2018-12-31 2018-12-31 一种新型嵌合dna聚合酶及其制备方法

Publications (2)

Publication Number Publication Date
CN109628424A true CN109628424A (zh) 2019-04-16
CN109628424B CN109628424B (zh) 2022-04-26

Family

ID=66056243

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811651584.3A Active CN109628424B (zh) 2018-12-31 2018-12-31 一种新型嵌合dna聚合酶及其制备方法

Country Status (1)

Country Link
CN (1) CN109628424B (zh)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021127848A1 (zh) * 2019-12-23 2021-07-01 深圳华大生命科学研究院 嵌合dna聚合酶及其应用
CN114015672A (zh) * 2021-12-06 2022-02-08 江南大学 一种Pfu DNA聚合酶
WO2023082266A1 (zh) * 2021-11-15 2023-05-19 深圳华大生命科学研究院 嵌合dna聚合酶及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008025A (en) * 1996-07-29 1999-12-28 Toyo Boseki Kabushiki Kaisha Modified thermostable DNA polymerase derived from pyrococcus sp. KOD and DNA polymerase composition thereof for nucleic acid amplification
US6033859A (en) * 1996-05-24 2000-03-07 Toyo Boseki Kabushiki Kaisha Thermostable DNA polymerase from a hyperthermophilic archaeon strain KOD1
US6054301A (en) * 1995-05-31 2000-04-25 Toyo Boseki Kabushiki Kaisha Methods of amplification using a thermostable DNA polymerase from the hyperthermophilic archaeon strain KOD1 and reagent kit therefor
CN102257136A (zh) * 2008-11-03 2011-11-23 卡帕生物系统 嵌合dna聚合酶
CN111996179A (zh) * 2020-08-21 2020-11-27 成都汇瑞新元生物科技有限责任公司 一种dna聚合酶及其在pcr检测中的应用

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054301A (en) * 1995-05-31 2000-04-25 Toyo Boseki Kabushiki Kaisha Methods of amplification using a thermostable DNA polymerase from the hyperthermophilic archaeon strain KOD1 and reagent kit therefor
US6033859A (en) * 1996-05-24 2000-03-07 Toyo Boseki Kabushiki Kaisha Thermostable DNA polymerase from a hyperthermophilic archaeon strain KOD1
US6008025A (en) * 1996-07-29 1999-12-28 Toyo Boseki Kabushiki Kaisha Modified thermostable DNA polymerase derived from pyrococcus sp. KOD and DNA polymerase composition thereof for nucleic acid amplification
CN102257136A (zh) * 2008-11-03 2011-11-23 卡帕生物系统 嵌合dna聚合酶
CN111996179A (zh) * 2020-08-21 2020-11-27 成都汇瑞新元生物科技有限责任公司 一种dna聚合酶及其在pcr检测中的应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HASHIMOTO,H ET AL: "PDB: 1WNS_A", 《NCBI》 *
韦慧等: "Pfu DNA聚合酶的制备过程及其条件优化", 《生命科学研究》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021127848A1 (zh) * 2019-12-23 2021-07-01 深圳华大生命科学研究院 嵌合dna聚合酶及其应用
CN114829593A (zh) * 2019-12-23 2022-07-29 深圳华大生命科学研究院 嵌合dna聚合酶及其应用
CN114829593B (zh) * 2019-12-23 2023-11-14 深圳华大生命科学研究院 嵌合dna聚合酶及其应用
WO2023082266A1 (zh) * 2021-11-15 2023-05-19 深圳华大生命科学研究院 嵌合dna聚合酶及其应用
CN114015672A (zh) * 2021-12-06 2022-02-08 江南大学 一种Pfu DNA聚合酶
CN114015672B (zh) * 2021-12-06 2022-05-31 江南大学 一种Pfu DNA聚合酶

Also Published As

Publication number Publication date
CN109628424B (zh) 2022-04-26

Similar Documents

Publication Publication Date Title
US5912155A (en) Cloned DNA polymerases from Thermotoga neapolitana
US7244602B2 (en) Polymerase chimeras
CN1482240B (zh) 具有削弱的3′-5′核酸外切酶活性的热稳定性的或热激活性的dna聚合酶分子
CA2268014C (en) Thermostable dna polymerase from carboxydothermus hydrogenoformans
CN107475216B (zh) 重组型耐热dna聚合酶及其应用
Dąbrowski et al. Cloning and Expression inEscherichia Coliof the Recombinant His-Tagged DNA Polymerases fromPyrococcus furiosusandPyrococcus Woesei
JP2000508538A (ja) バシラス ステアロテルモフィルスdnaポリメラーゼの生物学的に活性な断片
CN109628424A (zh) 一种新型嵌合dna聚合酶及其制备方法
US11028376B2 (en) DNA polymerases from the red sea brine pool
JP2007532116A (ja) 1成分型および2成分型のDNAPolIIIレプリカーゼとその使用
KR100777227B1 (ko) 고호열성 dna 중합효소 및 이의 제조방법
Kim et al. Cloning, purification, and characterization of a new DNA polymerase from a hyperthermophilic archaeon, Thermococcus sp. NA1
CA2415767A1 (en) High fidelity polymerases and uses thereof
KR100777230B1 (ko) 써모코커스 유래 돌연변이 dna 중합효소들 및 그의유전자들
JP4285615B2 (ja) アネロセルム・サーモフィルム由来の耐熱性dnaポリメラーゼ
Kim et al. Improved thermostability and PCR efficiency of Thermococcus celericrescens DNA polymerase via site-directed mutagenesis
CN114829593B (zh) 嵌合dna聚合酶及其应用
Ali et al. Family B DNA polymerase from a hyperthermophilic archaeon Pyrobaculum calidifontis: cloning, characterization and PCR application
CN113755465A (zh) 嵌合体dna聚合酶及其制备方法
HEA-JIN et al. Cloning, expression, and characterization of a family B-type DNA polymerase from the hyperthermophilic crenarchaeon Pyrobaculum arsenaticum and its application to PCR
US20230107606A1 (en) B-family dna polymerase variant and kit comprising the same
US20230133012A1 (en) Nucleic acid polymerase variants, kits and methods for template-independent rna synthesis
Song et al. Characterization and PCR performance of a family B-type DNA polymerase from the hyperthermophilic crenarchaeon Staphylothermus marinus
Lee et al. Cloning, expression, and partial characterization of a family B-type DNA polymerase from the hyperthermophilic crenarchaeon Sulfophobococcus zilligii
Li et al. EXPRESSION AND PURIFICATION OF DNA POLYMERASE FROM THERMUS THERMOPHILUSINE. COLI EXPRESSION SYSTEM

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 215200 floor 3 and 4, No. 228, yunchuang Road, Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province

Applicant after: Suzhou inshore protein Technology Co.,Ltd.

Address before: 215200 comprehensive building of science and technology entrepreneurship Park, Wujiang Economic Development Zone, Wujiang District, Suzhou City, Jiangsu Province

Applicant before: WUJIANG NOVOPROTEIN SCIENTIFIC Inc.

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant